Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gough

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Human Gene Therapy|August 7, 2002
Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?Kevin Harrington, Luis Alvarez-Vallina, Marka Crittenden, et al.
BMJ (Clinical Research Ed.)|June 6, 2007
Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic reviewRos Collins, Jane Burch, Gillian Cranny, et al.
European Radiology|May 13, 2004
Renal artery aneurysms: diagnosis and surveillance with 3D contrast-enhanced magnetic resonance angiographyRonan F J Browne, Elaine O Riordan, Jacqueline A Roberts, et al.
Cancer Research|October 3, 2002
Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusionEmmanouela Linardakis, Andrew Bateman, Vy Phan, et al.
American Journal of Surgery|April 18, 2013
Circulating and intratumoral macrophages in patients with hepatocellular carcinoma: correlation with therapeutic approachPippa Newell, Ben Cottam, Talicia Savage, et al.
Frontiers in Oncology|July 5, 2021
Explant Modeling of the Immune Environment of Head and Neck CancerShay Sharon, Thomas Duhen, Shelly Bambina, et al.
Nature Biotechnology|March 5, 2002
Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cellsJohn Chester, Anja Ruchatz, Michael Gough, et al.
Nature Medicine|August 20, 2003
A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccinesVy Phan, Fiona Errington, S Chiat Cheong, et al.
Cancer Research|June 18, 2003
Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapyMarka Crittenden, Michael Gough, John Chester, et al.
Science Translational Medicine|July 16, 2010
The demographic and biomedical case for late-life interventions in agingMichael J Rae, Robert N Butler, Judith Campisi, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Human Gene Therapy|August 7, 2002
Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?Kevin Harrington, Luis Alvarez-Vallina, Marka Crittenden, et al.
BMJ (Clinical Research Ed.)|June 6, 2007
Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic reviewRos Collins, Jane Burch, Gillian Cranny, et al.
European Radiology|May 13, 2004
Renal artery aneurysms: diagnosis and surveillance with 3D contrast-enhanced magnetic resonance angiographyRonan F J Browne, Elaine O Riordan, Jacqueline A Roberts, et al.
Cancer Research|October 3, 2002
Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusionEmmanouela Linardakis, Andrew Bateman, Vy Phan, et al.
American Journal of Surgery|April 18, 2013
Circulating and intratumoral macrophages in patients with hepatocellular carcinoma: correlation with therapeutic approachPippa Newell, Ben Cottam, Talicia Savage, et al.
Frontiers in Oncology|July 5, 2021
Explant Modeling of the Immune Environment of Head and Neck CancerShay Sharon, Thomas Duhen, Shelly Bambina, et al.
Nature Biotechnology|March 5, 2002
Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cellsJohn Chester, Anja Ruchatz, Michael Gough, et al.
Nature Medicine|August 20, 2003
A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccinesVy Phan, Fiona Errington, S Chiat Cheong, et al.
Cancer Research|June 18, 2003
Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapyMarka Crittenden, Michael Gough, John Chester, et al.
Science Translational Medicine|July 16, 2010
The demographic and biomedical case for late-life interventions in agingMichael J Rae, Robert N Butler, Judith Campisi, et al.
Pageof 4